Study of the Combination of TACE With Apatinib in Patients With Hepatocellular Carcinoma

NCT03066557 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

PROCEDURE: TACE and Apatinib
PROCEDURE: TACE

Sponsor

Jiangsu Cancer Institute & Hospital

Collaborators

[object Object]